1. Hong Kong Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
C-MER Medical Holdings Limited

C-MER Medical Holdings Limited

HHKEX:3309
0.82
HKD
+0.01
(+1.24%)
1.12BMarket Cap
Mar 30Next Earn
C-MER Medical Holdings Limited
HKEX:3309
(Hong Kong Exchange)

Recent

price

0.82

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
HKD
0.16
0.2
0.25
0.31
0.42
0.55
0.63
0.97
1.4
1.53
1.55
1.61
- -
Revenue per Share
0.02
0.04
0.05
0.04
0.04
0.04
-0.01
0.02
-0.02
0.05
-0.11
0.08
- -
Basic EPS, GAAP
0.03
0.05
0.04
- -
0.01
-0.03
-0.1
0.01
0.06
0.2
0.1
0.17
- -
Free Cash Flow per Basic Share
- -
- -
- -
0.07
- -
0.02
0.02
0.02
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.07
0.06
0.16
0.81
0.81
1.13
1.16
1.48
1.47
1.41
1.49
1.54
Book Value per Share
0.03
0.07
0.06
0.15
0.8
0.67
0.71
0.69
0.59
0.6
0.63
0.63
0.67
Tangible Book Value per Share
1,000
1,000
1,000
1,000
1,022
1,046
1,104
1,148
1,233
1,256
1,233
1,206
1,190
Basic Weighted Avg Shares
156
199
249
311
429
576
700
1,113
1,732
1,924
1,913
1,947
- -
Sales/Revenue/Turnover
19.22
25.38
22.75
18.13
13.03
8.37
-0.91
0.19
-0.9
6.22
2.85
6.94
- -
Operating Margin (%)
11
12
12
9
26
79
114
149
224
221
331
199
- -
Depreciation Expense
22
38
47
40
43
41
-6
22
-22
62
-135
100
- -
Net Income, GAAP
20.03
20.8
19.98
31.39
30.4
26.47
435.94
39.61
- -
30.53
- -
28.51
- -
Effective Tax Rate (%)
14.29
19.29
18.86
12.89
9.91
7.19
-0.89
1.96
-1.26
3.22
-7.06
5.16
- -
Profit Margin (%)
-12
32
22
35
711
452
459
338
332
331
230
203
214
Working Capital
7
6
1
1
2
128
177
206
303
246
299
256
261
LT Debt
31
67
63
157
834
861
1,297
1,337
1,998
1,993
1,890
1,937
1,995
Total Equity
- -
41.68
48.82
31.2
8.43
3.7
-2.09
0.89
- -
3.42
- -
5.07
- -
Return on Invested Capital (%)
- -
44.92
52.28
32.62
8.51
5.27
-3.02
2.11
- -
2.09
- -
4.56
- -
Return on Capital (%)
- -
78.47
71.92
36.34
8.59
4.9
-0.58
1.67
-1.37
3.34
-7.51
5.69
- -
Return on Common Equity (%)

Capital Structure

HKD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
147
171
173
LT Borrowings
13
- -
- -
LT Finance Leases
263
256
261
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,181
1,190
1,189
Market Capitalization
2,125
2,047
1,117

Working Capital

HKD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
635
671
748
Cash, Cash Equivalents & STI
436
466
563
Accounts Receivable, Net
67
66
58
Inventories
53
51
55
Total Current Liabilities
420
468
534
Payables & Accruals
- -
- -
- -
ST Debt
147
171
173
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
67.6%
9.91%
2.47%
Free Cash Flow
-65.74%
103.79%
63.73%
Net Income, GAAP
-162.96%
-305.15%
-174.26%
Sales/Revenue/Turnover
27.08%
25.4%
1.75%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,913
2025
- -
- -
1,947
2026
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.11
2025
- -
- -
0.08
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
C-MER Medical Holdings Limited is a Hong Kong-based integrated medical group specializing in comprehensive specialty medical services with a core focus on ophthalmology. The company operates through multiple business segments including ophthalmic services, dental services, oncology, medical aesthetics, and general practice. It offers a broad range of products and services including cataract, glaucoma, strabismus, and refractive surgeries; vision aid products such as glasses and lenses; pharmaceutical and medical consumables; as well as specialized medical examinations and treatments. C-MER Medical manages over 30 medical facilities across Hong Kong and maintains a nationwide network of eye and dental hospitals and clinics in Mainland China, including major cities in the Greater Bay Area such as Shenzhen and Guangzhou, as well as Beijing, Shanghai, Kunming, and Huizhou. Founded in 2012 and headquartered in Central, Hong Kong, the company employs more than 1,400 staff and operates with a commitment to professional, high-quality, one-stop specialty medical care. Recently, C-MER Medical Holdings Limited completed a strategic Series A investment of US$1 million into Health Hope Pharma, a clinical-stage biotech company focusing on oral anti-cancer drug development, which has expanded the company’s portfolio into oncology pharmaceutical innovation. The company also changed its name from C-MER Eye Care Holdings Limited to C-MER Medical Holdings Limited in June 2024 to reflect its broadened healthcare service offerings beyond eye care. Additionally, C-MER Medical has engaged in share repurchase programs to optimize its capital structure. These developments signify the company's strategic expansion in both geographic reach and service breadth, reinforcing its position in the healthcare industry across Hong Kong and Mainland China.